112 related articles for article (PubMed ID: 16102752)
1. Modulating furin activity with designed mini-PDX peptides: synthesis and in vitro kinetic evaluation.
Basak A; Lotfipour F
FEBS Lett; 2005 Aug; 579(21):4813-21. PubMed ID: 16102752
[TBL] [Abstract][Full Text] [Related]
2. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis.
Siegfried G; Basak A; Cromlish JA; Benjannet S; Marcinkiewicz J; Chrétien M; Seidah NG; Khatib AM
J Clin Invest; 2003 Jun; 111(11):1723-32. PubMed ID: 12782675
[TBL] [Abstract][Full Text] [Related]
3. Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage.
Bergeron E; Basak A; Decroly E; Seidah NG
Biochem J; 2003 Jul; 373(Pt 2):475-84. PubMed ID: 12691605
[TBL] [Abstract][Full Text] [Related]
4. Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes.
Basak A; Lazure C
Biochem J; 2003 Jul; 373(Pt 1):231-9. PubMed ID: 12662153
[TBL] [Abstract][Full Text] [Related]
5. Engineering of α1-antitrypsin variants with improved specificity for the proprotein convertase furin using site-directed random mutagenesis.
Hada K; Isshiki K; Matsuda S; Yuasa K; Tsuji A
Protein Eng Des Sel; 2013 Feb; 26(2):123-31. PubMed ID: 23155057
[TBL] [Abstract][Full Text] [Related]
6. Involvement of furin-like proprotein convertases in the arterial response to injury.
Sluijter JP; Verloop RE; Pulskens WP; Velema E; Grimbergen JM; Quax PH; Goumans MJ; Pasterkamp G; de Kleijn DP
Cardiovasc Res; 2005 Oct; 68(1):136-43. PubMed ID: 15963479
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of convertase-related processing of proendothelin-1.
Denault JB; D'Orléans-Juste P; Masaki T; Leduc R
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S47-50. PubMed ID: 8587448
[TBL] [Abstract][Full Text] [Related]
8. A novel enediynyl peptide inhibitor of furin that blocks processing of proPDGF-A, B and proVEGF-C.
Basak A; Khatib AM; Mohottalage D; Basak S; Kolajova M; Bag SS; Basak A
PLoS One; 2009 Nov; 4(11):e7700. PubMed ID: 19956642
[TBL] [Abstract][Full Text] [Related]
9. alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent.
Jean F; Stella K; Thomas L; Liu G; Xiang Y; Reason AJ; Thomas G
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7293-8. PubMed ID: 9636142
[TBL] [Abstract][Full Text] [Related]
10. The potent inhibitory activity of histone H1.2 C-terminal fragments on furin.
Han J; Zhang L; Shao X; Shi J; Chi C
FEBS J; 2006 Oct; 273(19):4459-69. PubMed ID: 16956366
[TBL] [Abstract][Full Text] [Related]
11. Identification of serpin determinants of specificity and selectivity for furin inhibition through studies of α1PDX (α1-protease inhibitor Portland)-serpin B8 and furin active-site loop chimeras.
Izaguirre G; Qi L; Lima M; Olson ST
J Biol Chem; 2013 Jul; 288(30):21802-14. PubMed ID: 23744066
[TBL] [Abstract][Full Text] [Related]
12. Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region.
Fujisawa D; Yamazaki Y; Lomonte B; Morita T
Biochem J; 2008 May; 411(3):515-22. PubMed ID: 18251716
[TBL] [Abstract][Full Text] [Related]
13. In vitro elucidation of substrate specificity and bioassay of proprotein convertase 4 using intramolecularly quenched fluorogenic peptides.
Basak S; Chrétien M; Mbikay M; Basak A
Biochem J; 2004 Jun; 380(Pt 2):505-14. PubMed ID: 14972029
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements for furin-induced cleavage and activation of Shiga toxin.
Kurmanova A; Llorente A; Polesskaya A; Garred O; Olsnes S; Kozlov J; Sandvig K
Biochem Biophys Res Commun; 2007 May; 357(1):144-9. PubMed ID: 17407762
[TBL] [Abstract][Full Text] [Related]
15. The structure of the TGF-beta latency associated peptide region determines the ability of the proprotein convertase furin to cleave TGF-betas.
Kusakabe M; Cheong PL; Nikfar R; McLennan IS; Koishi K
J Cell Biochem; 2008 Jan; 103(1):311-20. PubMed ID: 17516499
[TBL] [Abstract][Full Text] [Related]
16. Engineering a Constrained Peptidic Scaffold towards Potent and Selective Furin Inhibitors.
Fittler H; Depp A; Avrutina O; Dahms SO; Than ME; Empting M; Kolmar H
Chembiochem; 2015 Nov; 16(17):2441-4. PubMed ID: 26426719
[TBL] [Abstract][Full Text] [Related]
17. Conformational analyses of a partially-folded bioactive prodomain of human furin.
Bhattacharjya S; Xu P; Wang P; Osborne MJ; Ni F
Biopolymers; 2007 Jul; 86(4):329-44. PubMed ID: 17477394
[TBL] [Abstract][Full Text] [Related]
18. Alpha1-antitrypsin Portland inhibits processing of precursors mediated by proprotein convertases primarily within the constitutive secretory pathway.
Benjannet S; Savaria D; Laslop A; Munzer JS; Chrétien M; Marcinkiewicz M; Seidah NG
J Biol Chem; 1997 Oct; 272(42):26210-8. PubMed ID: 9334189
[TBL] [Abstract][Full Text] [Related]
19. Characterization and development of a peptide substrate-based phosphate transfer assay for the human vascular endothelial growth factor receptor-2 tyrosine kinase.
Zhao G; Peery RB; Yingling JM
Anal Biochem; 2007 Jan; 360(2):196-206. PubMed ID: 17141171
[TBL] [Abstract][Full Text] [Related]
20. Serpin-like properties of alpha1-antitrypsin Portland towards furin convertase.
Dufour EK; Denault JB; Hopkins PC; Leduc R
FEBS Lett; 1998 Apr; 426(1):41-6. PubMed ID: 9598975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
